Drug may curb female infertility from cancer treatments

September 1, 2017 by Krishna Ramanujan
A mouse ovary with proteins specific to oocytes labelled in red and yellow. The study reports that culturing such ovaries in the presence of a drug that inhibits DNA damage checkpoint enzymes protects the oocytes from lethal levels of radiation that would normally kill the entire oocyte reserve (small oocytes in picture). Credit: Schimenti Lab, Cornell University

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a new study.

Women who are treated for with radiation or certain chemotherapy drugs are commonly rendered sterile. According to a 2006 study from Weill Cornell Medicine, nearly 40 percent of all female breast cancer survivors experience premature ovarian failure, in which they lose normal function of their ovaries and often become infertile.

Women are born with a lifetime reserve of oocytes, or immature eggs, but those oocytes are among the most sensitive cells in the body and may be wiped out by such cancer treatments.

The current study, published in the journal Genetics, was led by John Schimenti, Cornell University professor in the Departments of Biomedical Sciences and Molecular Biology and Genetics. The study builds on his 2014 research that identified a so-called checkpoint protein (CHK2) that becomes activated when oocytes are damaged by radiation.

CHK2 functions in a pathway that eliminates oocytes with DNA damage, a natural function to protect against giving birth to offspring bearing new mutations. When the researchers irradiated mice lacking the CHK2 gene, the oocytes survived, eventually repaired the DNA damage, and the mice gave birth to healthy pups.

The new study explored whether the checkpoint 2 pathway could be chemically inhibited.

"It turns out there were pre-existing CHK2 inhibitor drugs that were developed, ironically enough, for , but they turned out not to be very useful for treating cancer," said Schimenti, the paper's senior author. Vera Rinaldi, a graduate student in Schimenti's lab, is the paper's first author. "By giving mice the inhibitor drug, a small molecule, it essentially mimicked the knockout of the checkpoint gene," Rinaldi said.

By inhibiting the checkpoint pathway, the oocytes were not killed by radiation and remained fertile, enabling birth of normal pups.

"The one major concern," Schimenti said, "is that even though these irradiated oocytes led to the birth of healthy mouse pups, it's conceivable that they harbor mutations that will become manifested in a generation or two, because we are circumventing an evolutionarily important mechanism of genetic quality control. This needs to be investigated by genome sequencing."

When doctors recognize the need for -damaging cancer treatments, women may have their oocytes or even ovarian tissue removed and frozen, but this practice delays treatment. Also, when women run out of oocytes, women's bodies naturally undergo menopause, as their hormonal systems shift.

"That is a serious dilemma and emotional issue," Schimenti said, "when you layer a cancer diagnosis on top of the prospect of having permanent life-altering effects as a result of chemotherapy, and must face the urgent decision of delaying to freeze oocytes at the risk of one's own life."

The study sets a precedent for co-administering this or related drugs and starting cancer therapy simultaneously, though such interventions would first require lengthy human trials.

"While humans and mice have different physiologies, and there is much work to be done to determine safe and effective dosages for people, it is clear that we have the proof of principle for this approach," Schimenti said.

Explore further: Protein that culls damaged eggs identified, infertility reversed

Related Stories

Protein that culls damaged eggs identified, infertility reversed

January 30, 2014
(Medical Xpress)—A new discovery by Cornell researchers may lead to therapies that allow women who are made infertile by radiation or chemotherapy treatments to have children.

Blocking apoptotic response could preserve fertility in women receiving cancer treatments

May 17, 2016
Female cancer patients of reproductive age could preserve their fertility during radiation and chemotherapy through treatments that target the DNA damage response in oocytes (the cells that develop into eggs), an approach ...

Mouse study looks at safety of stem cell therapy for early menopause

May 18, 2017
Now that we know that egg-making stem cells exist in adult rodents and humans and that these cells can be transplanted into mice with premature ovarian failure to produce offspring, the next question is to assess whether ...

Preventing eggs' death from chemotherapy

June 17, 2013
Young women who have cancer treatment often lose their fertility because chemotherapy and radiation can damage or kill their immature ovarian eggs, called oocytes. Now, Northwestern Medicine scientists have found the molecular ...

The more eggs the better in IVF?

July 3, 2017
A higher number of eggs retrieved in an IVF treatment cycle is independently associated with more chromosomally normal embryos available for transfer, according to a new Australian study. However, the benefit of a greater ...

Recommended for you

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

New study reveals breast cancer cells recycle their own ammonia waste as fuel

October 19, 2017
Breast cancer cells recycle ammonia, a waste byproduct of cell metabolism, and use it as a source of nitrogen to fuel tumor growth, report scientists from Harvard Medical School in the journal Science.

5 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

somefingguy
1 / 5 (1) Sep 02, 2017
Is it really a smart thing to do though, let people who are predisposed to cancer breed again?
MarsBars
5 / 5 (1) Sep 04, 2017
Is it really a smart thing to do though, let people who are predisposed to cancer breed again?

I'm curious, somefingguy - does your comment apply equally to people who have prostate cancer or testicular cancer?
somefingguy
1 / 5 (1) Sep 06, 2017
Is it really a smart thing to do though, let people who are predisposed to cancer breed again?

I'm curious, somefingguy - does your comment apply equally to people who have prostate cancer or testicular cancer?


Yes, it does. Cancer usually indicates a lot of mutations which you would not want to pass on. I am not against trying to save those people, but perhaps we shouldn't let them pass on clearly mutated (not a positive mutation) DNA.
MarsBars
5 / 5 (1) Sep 07, 2017
Cancer usually indicates a lot of mutations which you would not want to pass on. I am not against trying to save those people, but perhaps we shouldn't let them pass on clearly mutated (not a positive mutation) DNA.

Given that, in most cases, breast cancer, prostate cancer and (to a somewhat lesser extent) testicular cancer arises after the person has already reproduced, how would society go about implementing and policing a policy such as you are proposing? How successful do you think efforts would be in convincing the existing offspring of post-reproductive cancer sufferers from reproducing? How do you envision preventing them from doing so, particularly when there would also be religious opposition and human rights opposition in addition to opposition from the individuals themselves? How would you clearly distinguish between cancers resulting from a genetic legacy and cancers due to environmental or personal behavior causes?
Captain Stumpy
5 / 5 (1) Sep 08, 2017
perhaps we shouldn't let them pass on clearly mutated (not a positive mutation) DNA
@somefingguy
i downrated your posts because they don't take anything into consideration (google scholar is your friend - use it)

this attitude is especially heinous given that we have successfully modified DNA - https://www.ncbi.nlm.nih.gov

the problem with it is: the morality of requested or forced alterations to DNA in utero (IOW- sans choice)

in point of fact: the biological imperative to reproduce is one of the most driving instincts of any living creature on earth (only the need to survive outweighs this one)

moreover, mixing DNA is how we evolved - mutation is a chance that we take every time we reproduce

.

so what about mitigating factors like exposure?

do ya suggest offing all those folk too because they don't have the requisite DNA to fight said exposure like other animals or insects?

where is the line drawn?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.